# RISI in the Treatment of Recurrent Chest Wall Malignancies After EBRT

> **NCT04077710** · — · UNKNOWN · sponsor: **Peking University Third Hospital** · enrollment: 30 (estimated)

## Conditions studied

- Chest Wall Tumor

## Interventions

- **RADIATION:** Radioactive Iodine-125 Seeds Implantation

## Key facts

- **NCT ID:** NCT04077710
- **Lead sponsor:** Peking University Third Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-05-01
- **Primary completion:** 2024-04-30
- **Final completion:** 2025-04-30
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2023-12-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04077710

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04077710, "RISI in the Treatment of Recurrent Chest Wall Malignancies After EBRT". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04077710. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*